SCHEMBL31453548

SCHEMBL31453548

CCOC(=O)/C=C/C(=O)N(C)c1ccc(C#N)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 5/20 0.40
EGLN2 Q96KS0 1/20 0.37
CYP3A4 P08684 1/20 0.36
EPAS1 Q99814 1/20 0.36
CACNA1G O43497 1/20 0.35
CACNA1H O95180 1/20 0.35
CACNA1I Q9P0X4 1/20 0.35
CYP11B1 P15538 2/20 0.35
CYP11B2 P19099 2/20 0.35
TTR P02766 1/20 0.34
DPP4 P27487 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
MAPT P10636 3/20 0.34
MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31453600 0.91 NR1H4 (0.41) NR1H4CYP3A4EPAS1TTRDPP4
SCHEMBL31453654 0.85 CYP3A4 (0.40) CYP3A4TTRDPP4HCAR2CA12
SCHEMBL31453570 0.82 MAPT (0.41) CYP3A4TTRDPP4HCAR2CA12
SCHEMBL31453566 0.82 CYP3A4 (0.39) CYP3A4TTRDPP4HCAR2CA12
SCHEMBL31453617 0.81 FDPS (0.44) CYP3A4MAPTALDH1A1CYP2D6CYP2C9
SCHEMBL31453729 0.80 LMNA (0.38) CYP3A4CYP11B1CYP11B2TTRDPP4
SCHEMBL31453543 0.80 CNKSR1 (0.37) CYP3A4TTRDPP4HCAR2CA12
SCHEMBL31453677 0.80 ALDH1A1 (0.45) CYP3A4TTRDPP4MAPTALDH1A1
SCHEMBL31453539 0.79 MAPT (0.43) TTRDPP4HCAR2CA12CA1
SCHEMBL31453652 0.77 CYP3A4 (0.38) CYP3A4TTRDPP4HCAR2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025016138-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF SUZHOU EOC MEDICAL RESEARCH CO., LTD. (CN) 2025-01-23 WO disclosed